Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Schall

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Plos One|April 25, 2009
The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cellsNicolas Page, Nicolas Schall, Jean-Marc Strub, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2014
Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunityNishant Dwivedi, Indira Neeli, Nicolas Schall, et al.
Angiogenesis|October 1, 2015
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritisLuca Semerano, Emilie Duvallet, Nadia Belmellat, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Plos One|April 25, 2009
The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cellsNicolas Page, Nicolas Schall, Jean-Marc Strub, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2014
Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunityNishant Dwivedi, Indira Neeli, Nicolas Schall, et al.
Angiogenesis|October 1, 2015
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritisLuca Semerano, Emilie Duvallet, Nadia Belmellat, et al.
Pageof 3